Use of Patient-Derived Organoids as a Treatment Selection Model for Colorectal Cancer: A Narrative Review

SIMPLE SUMMARY: Colorectal cancer (CRC) is the third most common type of cancer globally. Despite successful treatment, it has a 40% chance of recurrence within five years after surgery. While neoadjuvant chemotherapy is offered for stage IV cancers, it comes with a risk of resistance and disease pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Furbo, Sara, Urbano, Paulo César Martins, Raskov, Hans Henrik, Troelsen, Jesper Thorvald, Kanstrup Fiehn, Anne-Marie, Gögenur, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870458/
https://www.ncbi.nlm.nih.gov/pubmed/35205817
http://dx.doi.org/10.3390/cancers14041069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870458/
https://www.ncbi.nlm.nih.gov/pubmed/35205817
http://dx.doi.org/10.3390/cancers14041069

Ejemplares similares